SillaJen starts US trial of anti-cancer drug from Basilea

SillaJen starts US trial of anti-cancer drug from Basilea

SillaJen Inc. said on Monday it has enrolled the first patient in a US phase 1 trial of an anti-cancer drug BAL0891 licensed from Swiss drugmaker Ba...

SillaJen shares jump as exchange maintains listing, allows resumed trade

SillaJen shares jump as exchange maintains listing, allows resumed trade

Shares in South Korea’s scandal-hit biotechnological company SillaJen Inc. soared on Thursday after the local exchange decided to maintain the...

President Lee meets Hyundai, LG chiefs, promotes ‘one team’ approach Hanwan Ocean wins $1.4 bn order to build 7 LNG dual-fuel ships K-content reign continues as Squid Game returns in force South Korea’s EV exports rebound in June after 16-month decline Yes, it’s K-beauty: Strong buying appetite for makeup brands even before they're up for sale
banner